Search

Your search keyword '"BERGEL F"' showing total 1,405 results

Search Constraints

Start Over You searched for: Author "BERGEL F" Remove constraint Author: "BERGEL F" Publisher springer berlin heidelberg Remove constraint Publisher: springer berlin heidelberg
1,405 results on '"BERGEL F"'

Search Results

2. Some Methods Used to Study the Granulopoietic System

3. Granulopoietic Toxicity of Cytotoxic Agents: Pathogenesis, Pathophysiology, Methods of Modulation, and Clinical Aspects

4. Effect of Individual Cytotoxic Agents Upon the Granulopoietic System

5. References

6. Biologic-Response Modifiers and Adjuvant Chemotherapy: Consideration of Selected Preclinical Investigations in Relation to Clinical Potential

7. Adjuvant Chemotherapy in Colon and Gastric Cancer

8. Metastatic CNS Disease in Small Cell Carcinoma of the Bronchus: The Role of Radiotherapy and Chemotherapy

9. Structure and Physiology of the Granulopoietic System

10. Adjuvant 5-Fluorouracil and BCNU Chemotherapy in Gastric Cancer: 3-Year Results

11. Preliminary Clinical Results with Norgamem (Thioproline) and Revercan (2-Amino-2-Thiazoline): The First Inducers of Reverse Transformation

12. Cellular Interactions Modulating Host Resistance to Tumours

13. Current Status of Clinical Trials of m-AMSA, Dihydroxyanthracenedione, and Deoxycoformycin

14. Emerging Immunologic Approaches, to Treatment of Neoplastic Diseases

15. Long-Term Cost of Combined Radiotherapy and Chemotherapy

16. Follow-Up Results from a Randomized Trial for T3 and T4 Breast Cancer Patients: Previous BCG Immunotherapy Improves Response to Chemotherapy in the Relapse Patient

17. Studies of Clonogenic Human Tumor Stem Cells

18. Clinical Trials on Adjuvant Therapies in Cancer: Short-Term and Long-Term Results

19. Chemotherapy of Carcinomas of the Digestive Tract

20. Chemotherapy of Metastatic Gastrointestinal Cancers: Prospects for Future Adjuvant Systemic Therapies

21. Adjuvant Therapy of Testicular Carcinoma

22. Current Status of Melanoma Chemotherapy and Immunotherapy

23. Follow-Up of a Randomized Trial for Oat Cell Carcinoma Evaluating the Efficacy of Peripheral Intravenous Nutrition (PIVN) as Adjunct Treatment

24. Clinical Trials of Chemotherapy and Chemoimmunotherapy in Primary Malignant Melanoma

25. Trial 6: Randomized Study of Prolonged Chemotherapy, Immunotherapy, and Chemoimmunotherapy as an Adjuvant to Surgery for Stage I and II Melanoma: A Progress Report

26. Specific Active Immunotherapy in Lung Cancer: The Induction of Long-Lasting Cellular Responses to Tumour-Associated Antigens

27. Malnutrition in Lung Cancer: Incidence, Prognostic Implications, and Pathogenesis

28. Immunologically Defined Prognostic Subgroups as Predictors of Response to BCG Immunotherapy

29. Intrapleural BCG Immunotherapy of Lung Cancer Patients

30. Interim Results of EORTC Protocol 08742: Comparison, After Irradiation of Locally Advanced Squamous Cell Bronchial Carcinoma, of Abstention, Immunotherapy, Combination Chemotherapy, or Chemoimmunotherapy

31. Adjuvant Intermittent Chemoimmunotherapy for Primary Breast Cancer: A Prospective Study with Immunologic Follow-Up

32. A New Adjuvant Treatment with PolyadenyliC-Polyuridylic Acid in Operable Breast Cancer

33. Short-Term and Long-Term Effects of Chemoimmunotherapy on Granulopoiesis: Adjuvant Therapy of Breast Cancer

34. Adjuvant Treatment of Node-Positive Breast Cancer with Adriamycin-Cyclophosphamide with or Without Radiation Therapy: Interim Results of an Ongoing Clinical Trial

35. Adjuvant Chemoimmunotherapy with LMF Plus BCG in Node-Negative and Node-Positive Breast Cancer — Intermediate Report at 4 Years

36. Role of Lung Irradiation in the Adjuvant Treatment of Osteosarcoma

37. A Randomized Trial of Postoperative Five-Versus Three-Drug Chemotherapy After Mastectomy: A Cancer and Leukemia Group B (CALGB) Study

38. Multimodal Therapy with CMF in Resectable Breast Cancer with Positive Axillary Nodes: The Milan Institute Experience

39. Adjuvant Chemotherapy in Breast Cancer

40. Natural History of Breast Cancer

41. Early Results of Combined Modality Therapy of Patients with Ewing’s Sarcoma

42. Ewing’s Sarcoma: 5-Year Survival Under Adjuvant Chemotherapy

43. Ewing’s Sarcoma: Treatment with High-Dose Radiation and Adjuvant Chemotherapy

44. A Strategic Adjuvant Therapy of Osteosarcoma

45. Adjuvant Chemotherapy in Ewing’s Sarcoma Patients

46. Adjuvant Interferon Treatment of Human Osteosarcoma

47. Maintenance Chemoimmunotherapy of Nonlymphoblastic Acute Leukemias

48. Therapeutic Effectiveness of Neuraminidase-Treated Allogeneic Myeloblasts as Immunogen in Acute Myelocytic Leukemia

49. Poor-Prognosis Acute Lymphoblastic Leukemias

50. An Intensive Chemo- or Chemoimmunotherapy Regimen for Patients with Intermediate and Poor-Prognosis Acute Lymphatic Leukemia and Leukemic Lymphoblastic Lymphosarcoma: Preliminary Results with 14-Month Median Follow-Up

Catalog

Books, media, physical & digital resources